Literature DB >> 21193413

Structure-activity analysis of cathepsin K/chondroitin 4-sulfate interactions.

Maia M Cherney1, Fabien Lecaille, Martin Kienitz, Ferez S Nallaseth, Zhenqiang Li, Michael N G James, Dieter Brömme.   

Abstract

In the presence of oligomeric chondroitin 4-sulfate (C4-S), cathepsin K (catK) forms a specific complex that was shown to be the source of the major collagenolytic activity in bone osteoclasts. C4-S forms multiple contacts with amino acid residues on the backside of the catK molecule that help to facilitate complex formation. As cathepsin L does not exhibit a significant collagenase activity in the presence or in the absence of C4-S, we substituted the C4-S interacting residues in catK with those of cathepsin L. Variants revealed altered collagenolytic activities with the largest inhibitory effect shown by the hexavariant M5. None of the variants showed a reduction in their gelatinolytic and peptidolytic activities when compared with wild-type catK, indicating no structural alteration within their active sites. However, the crystal structure of the M5 variant in the presence of oligomeric C4-S revealed a different binding of chondroitin 4-sulfate. C4-S is not continuously ordered as it is in the wild-type catK·C4-S complex. The orientation and the direction of the hexasaccharide on the catK surface have changed, so that the hexasaccharide is positioned between two symmetry-related molecules. Only one M5 variant molecule of the dimer that is present in the asymmetric unit interacts with C4-S. These substitutions have changed the mode of catK binding to C4-S and, as a result, have likely affected the collagenolytic potential of the variant. The data presented here support our hypothesis that distinct catK/C4-S interactions are necessary for the collagenolytic activity of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193413      PMCID: PMC3058997          DOI: 10.1074/jbc.M110.126706

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis.

Authors:  W S Hou; D Brömme; Y Zhao; E Mehler; C Dushey; H Weinstein; C S Miranda; C Fraga; F Greig; J Carey; D L Rimoin; R J Desnick; B D Gelb
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 2.  Production and activation of recombinant papain-like cysteine proteases.

Authors:  Dieter Brömme; Ferez S Nallaseth; Boris Turk
Journal:  Methods       Date:  2004-02       Impact factor: 3.608

3.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

4.  Inference of macromolecular assemblies from crystalline state.

Authors:  Evgeny Krissinel; Kim Henrick
Journal:  J Mol Biol       Date:  2007-05-13       Impact factor: 5.469

5.  Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates.

Authors:  Z Li; W S Hou; D Brömme
Journal:  Biochemistry       Date:  2000-01-25       Impact factor: 3.162

6.  Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate.

Authors:  Zhenqiang Li; Wu-Shiun Hou; Carlos R Escalante-Torres; Bruce D Gelb; Dieter Bromme
Journal:  J Biol Chem       Date:  2002-05-30       Impact factor: 5.157

7.  Structure activity relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one cathepsin K inhibitors.

Authors:  Dennis S Yamashita; Robert W Marquis; Ren Xie; Sirishkumar D Nidamarthy; Hye-Ja Oh; Jae U Jeong; Karl F Erhard; Keith W Ward; Theresa J Roethke; Brian R Smith; H-Y Cheng; Xiaoliu Geng; Fan Lin; Priscilla H Offen; Bing Wang; Neysa Nevins; Martha S Head; R Curtis Haltiwanger; Amy A Narducci Sarjeant; Louise M Liable-Sands; Baoguang Zhao; Ward W Smith; Cheryl A Janson; Enoch Gao; Thaddeus Tomaszek; Michael McQueney; Ian E James; Catherine J Gress; Denise L Zembryki; Michael W Lark; Daniel F Veber
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

8.  Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation.

Authors:  W S Hou; Z Li; R E Gordon; K Chan; M J Klein; R Levy; M Keysser; G Keyszer; D Brömme
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

9.  Selective inhibition of the collagenolytic activity of human cathepsin K by altering its S2 subsite specificity.

Authors:  Fabien Lecaille; Youngchool Choe; Wolfgang Brandt; Zhenqiang Li; Charles S Craik; Dieter Brömme
Journal:  Biochemistry       Date:  2002-07-02       Impact factor: 3.162

10.  Regulation of collagenase activities of human cathepsins by glycosaminoglycans.

Authors:  Zhenqiang Li; Yoshiyuki Yasuda; Weijie Li; Matthew Bogyo; Norman Katz; Ronald E Gordon; Gregg B Fields; Dieter Brömme
Journal:  J Biol Chem       Date:  2003-11-26       Impact factor: 5.157

View more
  15 in total

1.  Sulfation and cation effects on the conformational properties of the glycan backbone of chondroitin sulfate disaccharides.

Authors:  Christina E Faller; Olgun Guvench
Journal:  J Phys Chem B       Date:  2015-05-07       Impact factor: 2.991

2.  Chondroitin sulfate promotes activation of cathepsin K.

Authors:  Peter A Lemaire; Lingyi Huang; Ya Zhuo; Jun Lu; Carolyn Bahnck; Shawn J Stachel; Steve S Carroll; Le T Duong
Journal:  J Biol Chem       Date:  2014-06-23       Impact factor: 5.157

Review 3.  Interstitial collagen catabolism.

Authors:  Gregg B Fields
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

4.  Tanshinones that selectively block the collagenase activity of cathepsin K provide a novel class of ectosteric antiresorptive agents for bone.

Authors:  Preety Panwar; Simon Law; Andrew Jamroz; Pouya Azizi; Dongwei Zhang; Marco Ciufolini; Dieter Brömme
Journal:  Br J Pharmacol       Date:  2018-02-09       Impact factor: 8.739

Review 5.  Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.

Authors:  Achilleas D Theocharis; Chrisostomi Gialeli; Panagiotis Bouris; Efstathia Giannopoulou; Spyros S Skandalis; Alexios J Aletras; Renato V Iozzo; Nikos K Karamanos
Journal:  FEBS J       Date:  2014-11-06       Impact factor: 5.542

6.  Structural basis of collagen fiber degradation by cathepsin K.

Authors:  Adeleke H Aguda; Preety Panwar; Xin Du; Nham T Nguyen; Gary D Brayer; Dieter Brömme
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

7.  Glycan Activation of a Sheddase: Electrostatic Recognition between Heparin and proMMP-7.

Authors:  Yan G Fulcher; Stephen H Prior; Sayaka Masuko; Lingyun Li; Dennis Pu; Fuming Zhang; Robert J Linhardt; Steven R Van Doren
Journal:  Structure       Date:  2017-06-22       Impact factor: 5.006

8.  A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K.

Authors:  Preety Panwar; Kent Søe; Rafael Vc Guido; Renata V C Bueno; Jean-Marie Delaisse; Dieter Brömme
Journal:  Br J Pharmacol       Date:  2015-12-16       Impact factor: 8.739

9.  The role of basic amino acid surface clusters on the collagenase activity of cathepsin K.

Authors:  Ferez S Nallaseth; Fabien Lecaille; Zhenqiang Li; Dieter Brömme
Journal:  Biochemistry       Date:  2013-10-22       Impact factor: 3.162

Review 10.  Proteases involved in cartilage matrix degradation in osteoarthritis.

Authors:  Linda Troeberg; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2011-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.